|
|
Volumn 31, Issue 19, 2013, Pages
|
|
Clinical response to crizotinib retreatment after acquisition of drug resistance
a a a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANAPLASTIC LYMPHOMA KINASE;
CISPLATIN;
CRIZOTINIB;
DOCETAXEL;
EPIDERMAL GROWTH FACTOR RECEPTOR;
PEMETREXED;
ANTINEOPLASTIC AGENT;
CELL CYCLE PROTEIN;
DRUG DERIVATIVE;
EGFR PROTEIN, HUMAN;
EML4 ALK FUSION PROTEIN, HUMAN;
EML4 PROTEIN, HUMAN;
EML4-ALK FUSION PROTEIN, HUMAN;
GLUTAMIC ACID DERIVATIVE;
GUANINE;
MICROTUBULE ASSOCIATED PROTEIN;
ONCOPROTEIN;
PROTEIN TYROSINE KINASE;
PYRAZOLE DERIVATIVE;
PYRIDINE DERIVATIVE;
SERINE PROTEINASE;
ADULT;
ARTICLE;
BONE METASTASIS;
CANCER CHEMOTHERAPY;
CANCER SIZE;
CANCER STAGING;
CASE REPORT;
COUGHING;
DISEASE COURSE;
DRUG RESISTANCE;
DRUG RESPONSE;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENE MUTATION;
HUMAN;
HUMAN TISSUE;
LUNG ADENOCARCINOMA;
LUNG METASTASIS;
MALE;
MEDICAL HISTORY;
MULTIPLE CYCLE TREATMENT;
PHASE 1 CLINICAL TRIAL (TOPIC);
PLEURA FLUID;
PNEUMONIA;
PRIORITY JOURNAL;
RETREATMENT;
SMOKING;
TUMOR BIOPSY;
TUMOR REGRESSION;
UNSPECIFIED SIDE EFFECT;
WILD TYPE;
ADENOCARCINOMA;
BONE TUMOR;
DRUG ADMINISTRATION;
GENE REARRANGEMENT;
GENETICS;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METASTASIS;
METHODOLOGY;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE NEOPLASMS;
CARCINOMA, NON-SMALL-CELL LUNG;
CELL CYCLE PROTEINS;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE, NEOPLASM;
GENE REARRANGEMENT;
GLUTAMATES;
GUANINE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MICROTUBULE-ASSOCIATED PROTEINS;
MOLECULAR TARGETED THERAPY;
NEOPLASM STAGING;
ONCOGENE PROTEINS, FUSION;
PYRAZOLES;
PYRIDINES;
RECEPTOR PROTEIN-TYROSINE KINASES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RETREATMENT;
SERINE ENDOPEPTIDASES;
TREATMENT OUTCOME;
|
|
EID: 84883112344
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2012.46.4305 Document Type: Article |
|
Times cited : (13)
|
|
References (6)
|
